1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology
2.1. Introduction
2.2. Define: Research Objective
2.3. Determine: Research Design
2.4. Prepare: Research Instrument
2.5. Collect: Data Source
2.6. Analyze: Data Interpretation
2.7. Formulate: Data Verification
2.8. Publish: Research Report
2.9. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increasing prevalence of venous thromboembolism and cardiovascular disorders
5.1.1.2. Growing number of elderly and obese people
5.1.1.3. Increasing acceptance of novel oral anticoagulants
5.1.2. Restraints
5.1.2.1. Stringent regulations related to drug dosage and clinical approvals
5.1.3. Opportunities
5.1.3.1. Introduction of novel anticoagulation therapeutics and increasing R&D investments
5.1.3.2. Increasing collaboration activities and development of generic drugs
5.1.4. Challenges
5.1.4.1. Potential risk associated with the side-effects and complications associated with the usage of oral anticoagulants
5.2. Cumulative Impact of COVID-19

6. Anticoagulant Market, by Route of Administration
6.1. Introduction
6.2. Injectable Anticoagulants
6.3. Oral Anticoagulants

7. Anticoagulant Market, by Anticoagulant Drug
7.1. Introduction
7.2. Betrixaban
7.3. Dabigatran
7.4. Edoxaban / Rivaroxaban
7.5. Eliquis

8. Anticoagulant Market, by Drug Class
8.1. Introduction
8.2. DTIs
8.3. Factor XA Inhibitors
8.4. Heparin
8.5. Vitamin K Antagonists

9. Anticoagulant Market, by Application
9.1. Introduction
9.2. Atrial fibrillation & Heart Attack
9.3. Deep Vein Thrombosis
9.4. Pulmonary Embolism
9.5. Stroke

10. Americas Anticoagulant Market
10.1. Introduction
10.2. Argentina
10.3. Brazil
10.4. Canada
10.5. Mexico
10.6. United States

11. Asia-Pacific Anticoagulant Market
11.1. Introduction
11.2. Australia
11.3. China
11.4. India
11.5. Indonesia
11.6. Japan
11.7. Malaysia
11.8. Philippines
11.9. Singapore
11.10. South Korea
11.11. Taiwan
11.12. Thailand

12. Europe, Middle East & Africa Anticoagulant Market
12.1. Introduction
12.2. France
12.3. Germany
12.4. Italy
12.5. Netherlands
12.6. Qatar
12.7. Russia
12.8. Saudi Arabia
12.9. South Africa
12.10. Spain
12.11. United Arab Emirates
12.12. United Kingdom

13. Competitive Landscape
13.1. FPNV Positioning Matrix
13.1.1. Quadrants
13.1.2. Business Strategy
13.1.3. Product Satisfaction
13.2. Market Ranking Analysis
13.3. Market Share Analysis, By Key Player
13.4. Competitive Scenario
13.4.1. Merger & Acquisition
13.4.2. Agreement, Collaboration, & Partnership
13.4.3. New Product Launch & Enhancement
13.4.4. Investment & Funding
13.4.5. Award, Recognition, & Expansion

14. Company Usability Profiles
14.1. Akebia Therapeutics, Inc.
14.2. Aspen Pharmacare Holdings Limited
14.3. AstraZeneca PLC
14.4. Athenex, Inc.
14.5. Baxter Laboratories Pty Ltd.
14.6. Bayer AG
14.7. C.H. Boehringer Sohn AG & Ko. KG
14.8. Eli Lilly and Company
14.9. Johnson & Johnson
14.10. Mylan N.V.
14.11. Novartis AG
14.12. Pfizer Inc.
14.13. Sandoz International GmbH
14.14. Sanofi S.A.
14.15. Teva Pharmaceutical Industries Ltd.

15. Appendix
15.1. Discussion Guide
15.2. License & Pricing

List of Figures

FIGURE 1. GLOBAL ANTICOAGULANT MARKET: RESEARCH PROCESS
FIGURE 2. GLOBAL ANTICOAGULANT MARKET: MARKET DYNAMICS
FIGURE 3. GLOBAL ANTICOAGULANT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2020 VS 2027 (%)
FIGURE 4. GLOBAL ANTICOAGULANT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2020 VS 2027 (USD BILLION)
FIGURE 5. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL ANTICOAGULANT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2027
FIGURE 6. GLOBAL ANTICOAGULANT MARKET SIZE, BY INJECTABLE ANTICOAGULANTS, 2018-2027 (USD BILLION)
FIGURE 7. GLOBAL ANTICOAGULANT MARKET SIZE, BY INJECTABLE ANTICOAGULANTS, BY REGION, 2020 VS 2027 (USD BILLION)
FIGURE 8. GLOBAL ANTICOAGULANT MARKET SIZE, BY ORAL ANTICOAGULANTS, 2018-2027 (USD BILLION)
FIGURE 9. GLOBAL ANTICOAGULANT MARKET SIZE, BY ORAL ANTICOAGULANTS, BY REGION, 2020 VS 2027 (USD BILLION)
FIGURE 10. GLOBAL ANTICOAGULANT MARKET SIZE, BY ANTICOAGULANT DRUG, 2020 VS 2027 (%)
FIGURE 11. GLOBAL ANTICOAGULANT MARKET SIZE, BY ANTICOAGULANT DRUG, 2020 VS 2027 (USD BILLION)
FIGURE 12. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL ANTICOAGULANT MARKET SIZE, BY ANTICOAGULANT DRUG, 2027
FIGURE 13. GLOBAL ANTICOAGULANT MARKET SIZE, BY BETRIXABAN, 2018-2027 (USD BILLION)
FIGURE 14. GLOBAL ANTICOAGULANT MARKET SIZE, BY BETRIXABAN, BY REGION, 2020 VS 2027 (USD BILLION)
FIGURE 15. GLOBAL ANTICOAGULANT MARKET SIZE, BY DABIGATRAN, 2018-2027 (USD BILLION)
FIGURE 16. GLOBAL ANTICOAGULANT MARKET SIZE, BY DABIGATRAN, BY REGION, 2020 VS 2027 (USD BILLION)
FIGURE 17. GLOBAL ANTICOAGULANT MARKET SIZE, BY EDOXABAN / RIVAROXABAN, 2018-2027 (USD BILLION)
FIGURE 18. GLOBAL ANTICOAGULANT MARKET SIZE, BY EDOXABAN / RIVAROXABAN, BY REGION, 2020 VS 2027 (USD BILLION)
FIGURE 19. GLOBAL ANTICOAGULANT MARKET SIZE, BY ELIQUIS, 2018-2027 (USD BILLION)
FIGURE 20. GLOBAL ANTICOAGULANT MARKET SIZE, BY ELIQUIS, BY REGION, 2020 VS 2027 (USD BILLION)
FIGURE 21. GLOBAL ANTICOAGULANT MARKET SIZE, BY DRUG CLASS, 2020 VS 2027 (%)
FIGURE 22. GLOBAL ANTICOAGULANT MARKET SIZE, BY DRUG CLASS, 2020 VS 2027 (USD BILLION)
FIGURE 23. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL ANTICOAGULANT MARKET SIZE, BY DRUG CLASS, 2027
FIGURE 24. GLOBAL ANTICOAGULANT MARKET SIZE, BY DTIS, 2018-2027 (USD BILLION)
FIGURE 25. GLOBAL ANTICOAGULANT MARKET SIZE, BY DTIS, BY REGION, 2020 VS 2027 (USD BILLION)
FIGURE 26. GLOBAL ANTICOAGULANT MARKET SIZE, BY FACTOR XA INHIBITORS, 2018-2027 (USD BILLION)
FIGURE 27. GLOBAL ANTICOAGULANT MARKET SIZE, BY FACTOR XA INHIBITORS, BY REGION, 2020 VS 2027 (USD BILLION)
FIGURE 28. GLOBAL ANTICOAGULANT MARKET SIZE, BY HEPARIN, 2018-2027 (USD BILLION)
FIGURE 29. GLOBAL ANTICOAGULANT MARKET SIZE, BY HEPARIN, BY REGION, 2020 VS 2027 (USD BILLION)
FIGURE 30. GLOBAL ANTICOAGULANT MARKET SIZE, BY VITAMIN K ANTAGONISTS, 2018-2027 (USD BILLION)
FIGURE 31. GLOBAL ANTICOAGULANT MARKET SIZE, BY VITAMIN K ANTAGONISTS, BY REGION, 2020 VS 2027 (USD BILLION)
FIGURE 32. GLOBAL ANTICOAGULANT MARKET SIZE, BY APPLICATION, 2020 VS 2027 (%)
FIGURE 33. GLOBAL ANTICOAGULANT MARKET SIZE, BY APPLICATION, 2020 VS 2027 (USD BILLION)
FIGURE 34. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL ANTICOAGULANT MARKET SIZE, BY APPLICATION, 2027
FIGURE 35. GLOBAL ANTICOAGULANT MARKET SIZE, BY ATRIAL FIBRILLATION & HEART ATTACK, 2018-2027 (USD BILLION)
FIGURE 36. GLOBAL ANTICOAGULANT MARKET SIZE, BY ATRIAL FIBRILLATION & HEART ATTACK, BY REGION, 2020 VS 2027 (USD BILLION)
FIGURE 37. GLOBAL ANTICOAGULANT MARKET SIZE, BY DEEP VEIN THROMBOSIS, 2018-2027 (USD BILLION)
FIGURE 38. GLOBAL ANTICOAGULANT MARKET SIZE, BY DEEP VEIN THROMBOSIS, BY REGION, 2020 VS 2027 (USD BILLION)
FIGURE 39. GLOBAL ANTICOAGULANT MARKET SIZE, BY PULMONARY EMBOLISM, 2018-2027 (USD BILLION)
FIGURE 40. GLOBAL ANTICOAGULANT MARKET SIZE, BY PULMONARY EMBOLISM, BY REGION, 2020 VS 2027 (USD BILLION)
FIGURE 41. GLOBAL ANTICOAGULANT MARKET SIZE, BY STROKE, 2018-2027 (USD BILLION)
FIGURE 42. GLOBAL ANTICOAGULANT MARKET SIZE, BY STROKE, BY REGION, 2020 VS 2027 (USD BILLION)
FIGURE 43. AMERICAS ANTICOAGULANT MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 44. ARGENTINA ANTICOAGULANT MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 45. BRAZIL ANTICOAGULANT MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 46. CANADA ANTICOAGULANT MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 47. MEXICO ANTICOAGULANT MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 48. UNITED STATES ANTICOAGULANT MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 49. ASIA-PACIFIC ANTICOAGULANT MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 50. AUSTRALIA ANTICOAGULANT MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 51. CHINA ANTICOAGULANT MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 52. INDIA ANTICOAGULANT MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 53. INDONESIA ANTICOAGULANT MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 54. JAPAN ANTICOAGULANT MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 55. MALAYSIA ANTICOAGULANT MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 56. PHILIPPINES ANTICOAGULANT MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 57. SINGAPORE ANTICOAGULANT MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 58. SOUTH KOREA ANTICOAGULANT MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 59. TAIWAN ANTICOAGULANT MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 60. THAILAND ANTICOAGULANT MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 61. EUROPE, MIDDLE EAST & AFRICA ANTICOAGULANT MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 62. FRANCE ANTICOAGULANT MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 63. GERMANY ANTICOAGULANT MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 64. ITALY ANTICOAGULANT MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 65. NETHERLANDS ANTICOAGULANT MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 66. QATAR ANTICOAGULANT MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 67. RUSSIA ANTICOAGULANT MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 68. SAUDI ARABIA ANTICOAGULANT MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 69. SOUTH AFRICA ANTICOAGULANT MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 70. SPAIN ANTICOAGULANT MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 71. UNITED ARAB EMIRATES ANTICOAGULANT MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 72. UNITED KINGDOM ANTICOAGULANT MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 73. GLOBAL ANTICOAGULANT MARKET: FPNV POSITIONING MATRIX
FIGURE 74. GLOBAL ANTICOAGULANT MARKET: SHARE, BY KEY PLAYER, 2020
FIGURE 75. COMPETITIVE SCENARIO ANALYSIS IN GLOBAL ANTICOAGULANT MARKET, BY TYPE

List of Tables

TABLE 1. GLOBAL ANTICOAGULANT MARKET: MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2016-2020
TABLE 3. GLOBAL ANTICOAGULANT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD BILLION)
TABLE 4. GLOBAL ANTICOAGULANT MARKET SIZE, BY INJECTABLE ANTICOAGULANTS, BY REGION, 2018-2027 (USD BILLION)
TABLE 5. GLOBAL ANTICOAGULANT MARKET SIZE, BY ORAL ANTICOAGULANTS, BY REGION, 2018-2027 (USD BILLION)
TABLE 6. GLOBAL ANTICOAGULANT MARKET SIZE, BY ANTICOAGULANT DRUG, 2018-2027 (USD BILLION)
TABLE 7. GLOBAL ANTICOAGULANT MARKET SIZE, BY BETRIXABAN, BY REGION, 2018-2027 (USD BILLION)
TABLE 8. GLOBAL ANTICOAGULANT MARKET SIZE, BY DABIGATRAN, BY REGION, 2018-2027 (USD BILLION)
TABLE 9. GLOBAL ANTICOAGULANT MARKET SIZE, BY EDOXABAN / RIVAROXABAN, BY REGION, 2018-2027 (USD BILLION)
TABLE 10. GLOBAL ANTICOAGULANT MARKET SIZE, BY ELIQUIS, BY REGION, 2018-2027 (USD BILLION)
TABLE 11. GLOBAL ANTICOAGULANT MARKET SIZE, BY DRUG CLASS, 2018-2027 (USD BILLION)
TABLE 12. GLOBAL ANTICOAGULANT MARKET SIZE, BY DTIS, BY REGION, 2018-2027 (USD BILLION)
TABLE 13. GLOBAL ANTICOAGULANT MARKET SIZE, BY FACTOR XA INHIBITORS, BY REGION, 2018-2027 (USD BILLION)
TABLE 14. GLOBAL ANTICOAGULANT MARKET SIZE, BY HEPARIN, BY REGION, 2018-2027 (USD BILLION)
TABLE 15. GLOBAL ANTICOAGULANT MARKET SIZE, BY VITAMIN K ANTAGONISTS, BY REGION, 2018-2027 (USD BILLION)
TABLE 16. GLOBAL ANTICOAGULANT MARKET SIZE, BY APPLICATION, 2018-2027 (USD BILLION)
TABLE 17. GLOBAL ANTICOAGULANT MARKET SIZE, BY ATRIAL FIBRILLATION & HEART ATTACK, BY REGION, 2018-2027 (USD BILLION)
TABLE 18. GLOBAL ANTICOAGULANT MARKET SIZE, BY DEEP VEIN THROMBOSIS, BY REGION, 2018-2027 (USD BILLION)
TABLE 19. GLOBAL ANTICOAGULANT MARKET SIZE, BY PULMONARY EMBOLISM, BY REGION, 2018-2027 (USD BILLION)
TABLE 20. GLOBAL ANTICOAGULANT MARKET SIZE, BY STROKE, BY REGION, 2018-2027 (USD BILLION)
TABLE 21. AMERICAS ANTICOAGULANT MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 22. ARGENTINA ANTICOAGULANT MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 23. BRAZIL ANTICOAGULANT MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 24. CANADA ANTICOAGULANT MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 25. MEXICO ANTICOAGULANT MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 26. UNITED STATES ANTICOAGULANT MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 27. ASIA-PACIFIC ANTICOAGULANT MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 28. AUSTRALIA ANTICOAGULANT MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 29. CHINA ANTICOAGULANT MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 30. INDIA ANTICOAGULANT MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 31. INDONESIA ANTICOAGULANT MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 32. JAPAN ANTICOAGULANT MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 33. MALAYSIA ANTICOAGULANT MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 34. PHILIPPINES ANTICOAGULANT MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 35. SINGAPORE ANTICOAGULANT MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 36. SOUTH KOREA ANTICOAGULANT MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 37. TAIWAN ANTICOAGULANT MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 38. THAILAND ANTICOAGULANT MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 39. EUROPE, MIDDLE EAST & AFRICA ANTICOAGULANT MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 40. FRANCE ANTICOAGULANT MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 41. GERMANY ANTICOAGULANT MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 42. ITALY ANTICOAGULANT MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 43. NETHERLANDS ANTICOAGULANT MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 44. QATAR ANTICOAGULANT MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 45. RUSSIA ANTICOAGULANT MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 46. SAUDI ARABIA ANTICOAGULANT MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 47. SOUTH AFRICA ANTICOAGULANT MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 48. SPAIN ANTICOAGULANT MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 49. UNITED ARAB EMIRATES ANTICOAGULANT MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 50. UNITED KINGDOM ANTICOAGULANT MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 51. GLOBAL ANTICOAGULANT MARKET: SCORES
TABLE 52. GLOBAL ANTICOAGULANT MARKET: BUSINESS STRATEGY
TABLE 53. GLOBAL ANTICOAGULANT MARKET: PRODUCT SATISFACTION
TABLE 54. GLOBAL ANTICOAGULANT MARKET: RANKING
TABLE 55. GLOBAL ANTICOAGULANT MARKET: SHARE, BY KEY PLAYER, 2020
TABLE 56. GLOBAL ANTICOAGULANT MARKET: MERGER & ACQUISITION
TABLE 57. GLOBAL ANTICOAGULANT MARKET: AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 58. GLOBAL ANTICOAGULANT MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 59. GLOBAL ANTICOAGULANT MARKET: INVESTMENT & FUNDING
TABLE 60. GLOBAL ANTICOAGULANT MARKET: AWARD, RECOGNITION, & EXPANSION
TABLE 61. GLOBAL ANTICOAGULANT MARKET: LICENSE & PRICING

Companies Mentioned

Akebia Therapeutics, Inc.
Aspen Pharmacare Holdings Limited
AstraZeneca PLC
Athenex, Inc.
Baxter Laboratories Pty Ltd.
Bayer AG
C.H. Boehringer Sohn AG & Ko. KG
Eli Lilly and Company
Johnson & Johnson
Mylan N.V.
Novartis AG
Pfizer Inc.
Sandoz International GmbH
Sanofi S.A.
Teva Pharmaceutical Industries Ltd.